CRUS(CRUS)
CRUS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $2.11B | $2.19B |
| Low | $2.06B | $2.16B |
| High | $2.13B | $2.22B |
| EBITDA Avg | $733M | $763M |
| Low | $716M | $753M |
| High | $740M | $774M |
| EBIT Avg | $698M | $727M |
| Low | $682M | $717M |
| High | $705M | $737M |
| Net Income Avg | $468M | $497M |
| Low | $463M | $491M |
| High | $473M | $502M |
| EPS Avg | $8.90 | $9.48 |
| Low | $8.84 | $9.38 |
| High | $9.03 | $9.59 |
| Analysts (Rev / EPS) | 4 / 3 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $573M | $623M | $452M | $436M | $606M | $673M | $479M |
| Low | $558M | $613M | $444M | $429M | $596M | $662M | $471M |
| High | $583M | $630M | $457M | $441M | $613M | $681M | $485M |
| EBITDA Avg | $199M | $217M | $157M | $152M | $211M | $234M | $167M |
| Low | $194M | $213M | $155M | $149M | $207M | $230M | $164M |
| High | $203M | $219M | $159M | $153M | $213M | $237M | $169M |
| EBIT Avg | $190M | $206M | $150M | $144M | $201M | $223M | $159M |
| Low | $185M | $203M | $147M | $142M | $197M | $219M | $156M |
| High | $193M | $209M | $151M | $146M | $203M | $225M | $161M |
| Net Income Avg | $136M | $151M | $85M | $81M | $138M | $168M | $99M |
| Low | $134M | $148M | $83M | $80M | $135M | $164M | $97M |
| High | $138M | $153M | $86M | $83M | $140M | $170M | $100M |
| EPS Avg | $2.59 | $2.88 | $1.62 | $1.55 | $2.64 | $3.21 | $1.89 |
| Low | $2.55 | $2.82 | $1.59 | $1.52 | $2.58 | $3.14 | $1.85 |
| High | $2.63 | $2.92 | $1.65 | $1.58 | $2.68 | $3.25 | $1.92 |
| Analysts (Rev / EPS) | 4 / 3 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |